LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease via targeting miR-18a-5p/IGF1 axis

1. Tzouvelekis, A, Laurent, G, Bouros, D. Stem cell therapy in chronic obstructive pulmonary disease. Seeking the Prometheus effect. Curr Drug Targets 2013; 14: 246–252.
Google Scholar | Crossref | Medline2. Wang, C, Xu, J, Yang, L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018; 391: 1706–1717.
Google Scholar | Crossref | Medline3. Chen, PK, Hsiao, YH, Pan, SW, et al. Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: Focusing on the eosinophil-to-neutrophil ratio. PLoS One 2019; 14: e0218932.
Google Scholar | Medline4. Li, X, Ortega, VE, Ampleford, EJ, et al. Genome-wide association study of lung function and clinical implication in heavy smokers. BMC Med Genet 2018; 19: 134.
Google Scholar | Crossref | Medline5. De, la, Garza, MM, Cumpian, AM, Daliri, S, et al. COPD-type lung inflammation promotes K-ras mutant lung cancer through epithelial HIF-1alpha mediated tumor angiogenesis and proliferation. Oncotarget 2018; 9: 32972–32983.
Google Scholar | Crossref | Medline6. Kapellos, TS, Bassler, K, Aschenbrenner, AC, et al. Dysregulated functions of lung macrophage populations in COPD. J Immunol Res 2018; 2018: 2349045.
Google Scholar | Crossref | Medline7. Wu, X, Chen, D, Yu, L. The value of circulating long non-coding RNA maternally expressed gene 3 as a predictor of higher acute respiratory distress syndrome risk and 28-day mortality in sepsis patients. J Clin Lab Anal 2020; 34: e23488.
Google Scholar | Crossref | Medline8. Palmieri, G, Paliogiannis, P, Sini, MC, et al. Long non-coding RNA CASC2 in human cancer. Crit Rev Oncol Hematol 2017; 111: 31–38.
Google Scholar | Crossref | Medline9. Min, XQ, Xie, Y. LncRNA CASC2 alleviates the progression of diabetic nephropathy by regulating the miR-144/SOCS2 signalling axis. Kidney Blood Press Res 2020; 45: 837–849.
Google Scholar | Crossref | Medline10. Li, X, Mo, J, Li, J, et al. lncRNA CASC2 inhibits lipopolysaccharide-induced acute lung injury via miR-27b/TAB2 axis. Mol Med Rep 2020; 22: 5181–5190.
Google Scholar | Crossref | Medline11. Liu, X, Liu, X, Wu, Y, et al. MicroRNAs in biofluids are novel tools for bladder cancer screening. Oncotarget 2017; 8: 32370–32379.
Google Scholar | Crossref | Medline12. Wang, Y, Liu, Z, Yao, B, et al. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer 2017; 16: 123.
Google Scholar | Crossref | Medline13. Peng, L, Liu, YH, Nie, S, et al. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma. Eur Rev Med Pharmacol Sci 2020; 24: 8367–8376.
Google Scholar | Medline14. Brogaard, L, Larsen, LE, Heegaard, PMH, et al. IFN-lambda and microRNAs are important modulators of the pulmonary innate immune response against influenza A (H1N2) infection in pigs. PLoS One 2018; 13: e0194765.
Google Scholar | Crossref | Medline15. Yang, H, Zhang, Y, Li, W, et al. Altered microRNA expression profiles in lung damage induced by nanosized SiO2. Bioengineered 2017; 8: 45–54.
Google Scholar | Crossref | Medline16. Rabe, KF, Hurd, S, Anzueto, A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555.
Google Scholar | Crossref | Medline | ISI17. Moscovis, SM, Gordon, AE, Al Madani, OM, et al. Virus infections and sudden death in infancy: the role of interferon-gamma. Front Immunol 2015; 6: 107.
Google Scholar | Crossref | Medline18. Xu, W, Li, R, Sun, Y. Increased IFN-gamma-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease. BMC Pulm Med 2019; 19: 137.
Google Scholar | Crossref | Medline19. Ouyang, Y, Liu, X, Li, H, et al. RNA Sequencing analyses reveal the potential mechanism of pulmonary injury induced by gallium arsenide particles in human bronchial epithelioid cells. Sci Rep 2020; 10: 8685.
Google Scholar | Crossref | Medline20. Zhu, T, Shi, C, Li, H, et al. Curcumin suppresses cigarette smoke extract-induced oxidative stress through PPARgamma/NF-κB pathway in human bronchial epithelial cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2018; 38: 1209–1214.
Google Scholar | Medline21. Li, N, Liu, Y, Cai, J. LncRNA MIR155HG regulates M1/M2 macrophage polarization in chronic obstructive pulmonary disease. Biomed Pharmacother 2019; 117: 109015.
Google Scholar | Crossref | Medline22. Bi, H, Wang, G, Li, Z, et al. Long Noncoding RNA (lncRNA) Maternally Expressed Gene 3 (MEG3) participates in chronic obstructive pulmonary disease through regulating human pulmonary microvascular endothelial cell apoptosis. Med Sci Monit 2020; 26: e920793.
Google Scholar | Medline23. Ge, J, Geng, S, Jiang, H. Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease. J Clin Lab Anal 2019; 33: e22678.
Google Scholar | Crossref | Medline24. Wang, M, Wei, J, Shang, F, et al. Long noncoding RNA CASC2 ameliorates sepsis induced acute kidney injury by regulating the miR155 and NF-κB pathway. Int J Mol Med 2020; 45: 1554–1562.
Google Scholar | Medline25. Miao, WJ, Yuan, DJ, Zhang, GZ, et al. lncRNA CASC2/miR18a5p axis regulates the malignant potential of nasopharyngeal carcinoma by targeting RBBP8. Oncol Rep 2019; 41: 1797–1806.
Google Scholar | Medline26. Li, S, Jiang, L, Yang, Y, et al. MiR-195-5p inhibits the development of chronic obstructive pulmonary disease via targeting siglec1. Hum Exp Toxicol 2020; 39: 1333–1344.
Google Scholar | SAGE Journals27. Wu, Y, Guan, S, Ge, Y, et al. Cigarette smoke promotes chronic obstructive pulmonary disease (COPD) through the miR-130a/Wnt1 axis. Toxicol In Vitro 2020; 65: 104770.
Google Scholar | Crossref | Medline28. Chi, Y, Di, Q, Han, G, et al. Mir-29b mediates the regulation of Nrf2 on airway epithelial remodeling and Th1/Th2 differentiation in COPD rats. Saudi J Biol Sci 2019; 26: 1915–1921.
Google Scholar | Crossref | Medline29. Huang, Y, Zhao, L, Yan, Y, et al. PBMCs to stress-associated miR-18a-5p and miR-22-3p ratios as new indicators of metabolic syndrome. Biomed Res Int 2020; 2020: 8159342.
Google Scholar | Medline30. Castilla-Cortazar, I, Aguirre, GA, Femat-Roldan, G, et al. Is insulin-like growth factor-1 involved in Parkinson’s disease development? J Transl Med 2020; 18: 70.
Google Scholar | Crossref | Medline31. Liu, C, Wang, M, Chen, M, et al. miR-18a induces myotubes atrophy by down-regulating IgfI. Int J Biochem Cell Biol 2017; 90: 145–154.
Google Scholar | Crossref | Medline32. Coskun, F, Ege, E, Uzaslan, E, et al. Evaluation of thyroid hormone levels and somatomedin-C (IGF-1) in patients with Chronic Obstructive Pulmonary Disease (COPD) and relation with the severity of the disease. Tuberk Toraks 2009; 57: 369–375.
Google Scholar | Medline33. Crul, T, Spruit, MA, Gayan-Ramirez, G, et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest 2007; 37: 897–904.
Google Scholar | Crossref | Medline | ISI34. Roberston, MJ, Raghunathan, S, Potaman, VN, et al. CRISPR-Cas9-induced IGF1 gene activation as a tool for enhancing muscle differentiation via multiple isoform expression. FASEB J 2020; 34: 555–570.
Google Scholar | Crossref | Medline35. Sun, X, Chen, L, He, Z. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr Drug Metab 2019; 20: 301–304.
Google Scholar | Crossref | Medline36. Wang, Z, Li, R, Zhong, R. Extracellular matrix promotes proliferation, migration and adhesion of airway smooth muscle cells in a rat model of chronic obstructive pulmonary disease via upregulation of the PI3K/AKT signaling pathway. Mol Med Rep 2018; 18: 3143–3152.
Google Scholar | Medline

留言 (0)

沒有登入
gif